Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α
- 23 August 2024
- journal article
- research article
- Published by Elsevier in Cell Chemical Biology
- Vol. 31 (9) , 1729-1739.e9
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Bristol-Myers Squibb (1F31CA247527)
- National Institutes of Health
- University of California, San Francisco
- NCI (GM097316, NCI 1P41CA196276, CA191018)
- Sandler Foundation (P30CA082103)
This publication has 74 references indexed in Scilit:
- Systematic Functional Annotation of Somatic Mutations in CancerCancer Cell, 2018
- Systemic Immunity Is Required for Effective Cancer ImmunotherapyCell, 2017
- CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed PatientsThe American Journal of Pathology, 2016
- A Single Kinase Generates the Majority of the Secreted PhosphoproteomeCell, 2015
- CD109 is a potential target for triple-negative breast cancerTumor Biology, 2014
- A Secreted Tyrosine Kinase Acts in the Extracellular EnvironmentCell, 2014
- Chemical Genetic Approach for Kinase‐Substrate Mapping by Covalent Capture of Thiophosphopeptides and Analysis by Mass SpectrometryCurrent Protocols in Chemical Biology, 2010
- Protein Kinase CK2 in Health and DiseaseCellular and Molecular Life Sciences, 2009
- Activity of the E75E76 mutant of the α subunit of casein kinase II from Xenopus laevisFEBS Letters, 1994
- Thiophosphate-activated phosphorylase kinase as a probe in the regulation of phosphorylase phosphataseBiochimica et Biophysica Acta (BBA) - Enzymology, 1976